{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:53:40Z","timestamp":1779360820832,"version":"3.51.4"},"reference-count":34,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Surgical Infections"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Post-partum infection is a major contributor to maternal mortality and is responsible for approximately 10% of maternal fatalities worldwide. The risk of infection is substantially higher in cesarean section procedures. Approximately 8% of women who undergo cesarean sections are susceptible to infection. Although the body of evidence supporting the regular pre-operative utilization of prophylactic antibiotic treatment is steadily expanding, its usefulness in cesarean sections has not yet been standardized, and post-partum infection is still a serious medical challenge. We aimed to retrospectively assess the prophylactic effectiveness of cefazolin in combination with other antibiotic agents in cesarean sections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Both uni-variable and multi-variable analyses were conducted to identify factors that may affect cefazolin pre-operative antibiotic prophylaxis in elective cesarean section operations. The uni-variable analysis included timing of administration, operation duration, body mass index (BMI), and wound type. A multi-variable logistic regression model was then created to determine which variables provide independent information in the context of other variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Time of administration did not affect prophylactic cefazolin efficacy. However, prophylactic cefazolin was 1.43 and 1.77 times more effective when the operation lasted for 45 minutes or more, compared with operations that were shorter than 45 minutes. Patients with a BMI ranging from 18 to 29 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      showed increased efficacy of prophylactic cefazolin compared with obese patients with a BMI exceeding 30 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . The effectiveness of prophylactic cefazolin decreased by 95% in patients with clean-contaminated surgical incisions compared with those with clean surgical incisions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings demonstrate that administering pre-operative prophylactic antibiotic agents to women undergoing cesarean section resulted in a reduction in post-partum infections, thereby reducing maternal mortality. Furthermore, optimal timing of administration, re-dosing if necessary, length of prophylactic medication, and dosing adjustments for obese patients are crucial factors in preventing surgical site infections and promoting antimicrobial stewardship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/sur.2024.048","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T04:53:41Z","timestamp":1719982421000},"page":"513-520","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["A Retrospective Exploration of Pre-operative Antibiotic Prophylaxis with Cefazolin in Cesarean Sections: Implications for Obstetrics and Gynecologic Surgery"],"prefix":"10.1177","volume":"25","author":[{"given":"Alyaa S.","family":"Abdel Halim","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, Ain Shams University, Abbassia, Egypt."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-0262","authenticated-orcid":false,"given":"Mohamed A. M.","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia."},{"name":"Department of Biochemistry, Faculty of Science, Ain Shams University, Abbassia, Egypt."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruqiya","family":"Al Mamari","sequence":"additional","affiliation":[{"name":"Pharmacy Program, Department of Pharmacy Practice and Pharmaceutics, Oman College of Health Sciences, Muscat, Oman."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Al Raisi","sequence":"additional","affiliation":[{"name":"Pharmacy Program, Department of Pharmacology, Oman College of Health Sciences, Muscat, Oman."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fehmi","family":"Boufahja","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anis Ahmad","family":"Chaudhary","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael A. H.","family":"Hegazy","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt."},{"name":"Department of Pharmaceutical Sciences, Pharmacy Program, Oman College of Health Sciences, Muscat, Oman."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148343"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11091218"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2021.05.027"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002863"},{"issue":"2","key":"e_1_3_6_6_2","first-page":"143","article-title":"A randomised controlled trial of antibiotic prophylaxis in elective caesarean delivery","volume":"108","author":"Bagratee JS","year":"2001","unstructured":"Bagratee JS, , Moodley J, , Kleinschmidt I, et al. A randomised controlled trial of antibiotic prophylaxis in elective caesarean delivery. BJOG, 2001; 108(2):143\u2013148; doi: 10.1111\/j.1471-0528.2001.00042.x","journal-title":"BJOG"},{"issue":"1","key":"e_1_3_6_7_2","first-page":"CD000933","article-title":"Antibiotic prophylaxis for cesarean section","volume":"2010","author":"Smaill F","year":"2002","unstructured":"Smaill F, , Hofmeyr GJ. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev, 2002; 2010(1):CD000933; doi: 10.1002\/14651858.CD000933","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"e_1_3_6_8_2","first-page":"CD007482","article-title":"Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section","volume":"2014","author":"Smaill FM","year":"2010","unstructured":"Smaill FM, , Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev, 2010; 2014(10):CD007482; doi: 10.1002\/14651858.CD007482.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1681095"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2021.100360"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S98876"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/NMC.0000000000000598"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.06.068"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2023.02.012"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001899"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.06.077"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2013.56"},{"issue":"12","key":"e_1_3_6_18_2","first-page":"CD009516","article-title":"Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery","author":"Mackeen AD","year":"2014","unstructured":"Mackeen AD, , Packard RE, , Ota E, et al. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev, 2014(12):CD009516; doi: 10.1002\/14651858.CD009516.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"e_1_3_6_19_2","doi-asserted-by":"crossref","first-page":"e0129434","DOI":"10.1371\/journal.pone.0129434","article-title":"Timing of antibiotic prophylaxis in elective caesarean delivery: A multi-center randomized controlled trial and meta-analysis","volume":"10","author":"Zhang C","year":"2015","unstructured":"Zhang C, , Zhang L, , Liu X, et al. Timing of antibiotic prophylaxis in elective caesarean delivery: A multi-center randomized controlled trial and meta-analysis. PLoS One, 2015; 10(7):e0129434; doi: 10.1371\/journal.pone.0129434","journal-title":"PLoS One"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2017.0904"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000144"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2012.09.004"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13526"},{"issue":"3","key":"e_1_3_6_24_2","first-page":"178","article-title":"Cesarean delivery: Counseling issues and complication management","volume":"91","author":"Quinlan JD","year":"2015","unstructured":"Quinlan JD, , Murphy NJ. Cesarean delivery: Counseling issues and complication management. Am Fam Physician, 2015; 91(3):178\u2013184.","journal-title":"Am Fam Physician"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2021.05.011"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6909.2001.tb00011.x"},{"issue":"10","key":"e_1_3_6_27_2","first-page":"CD008726","article-title":"Different classes of antibiotics given to women routinely for preventing infection at caesarean section","author":"Alfirevic Z","year":"2010","unstructured":"Alfirevic Z, , Gyte GM, , Dou L. Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database Syst Rev, 2010(10):CD008726; doi: 10.1002\/14651858.CD008726","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"e_1_3_6_28_2","first-page":"CD008726","article-title":"Different classes of antibiotics given to women routinely for preventing infection at caesarean section","volume":"2014","author":"Gyte GM","year":"2014","unstructured":"Gyte GM, , Dou L, , Vazquez JC. Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database Syst Rev, 2014; 2014(11):CD008726; doi: 10.1002\/14651858.CD008726.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"e_1_3_6_29_2","first-page":"CD008726","article-title":"Different classes of antibiotics given to women routinely for preventing infection at caesarean section","volume":"3","author":"Williams MJ","year":"2021","unstructured":"Williams MJ, , Carvalho Ribeiro do Valle C, , Gyte GM, et al. Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database Syst Rev, 2021; 3(3):CD008726; doi: 10.1002\/14651858.CD008726.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000346458"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-017-1526-y"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.14373"},{"key":"e_1_3_6_33_2","first-page":"174550572211010","article-title":"Single-dose versus multiple-dose antibiotics prophylaxis for preventing caesarean section postpartum infections: A randomized controlled trial","volume":"18","author":"Igwemadu GT","year":"2022","unstructured":"Igwemadu GT, , Eleje GU, , Eno EE, et al. Single-dose versus multiple-dose antibiotics prophylaxis for preventing caesarean section postpartum infections: A randomized controlled trial. Womens Health (Lond), 2022; 18:17455057221101071; doi: 10.1177\/17455057221101071","journal-title":"Womens Health (Lond)"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.04.003"},{"issue":"5","key":"e_1_3_6_35_2","first-page":"551","article-title":"Antimicrobial stewardship","volume":"28","author":"Lanckohr C","year":"2022","unstructured":"Lanckohr C, , Bracht H. Antimicrobial stewardship. Curr Opin Crit Care, 2022; 28(5):551\u2013556; doi: 10.1097\/MCC.0000000000000967","journal-title":"Curr Opin Crit Care"}],"container-title":["Surgical Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/sur.2024.048","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/sur.2024.048","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/sur.2024.048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:31:14Z","timestamp":1777689074000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/sur.2024.048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,9,1]]}},"alternative-id":["10.1089\/sur.2024.048"],"URL":"https:\/\/doi.org\/10.1089\/sur.2024.048","relation":{},"ISSN":["1096-2964","1557-8674"],"issn-type":[{"value":"1096-2964","type":"print"},{"value":"1557-8674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}